CEBPA and acute myeloid leukemia: Furthermore, the survival analysis of a subcohort of 260 CN-AML patients with wt NPM1 and wt CEBPA revealed no prognostic impact of CEBPA distal PM (data not shown) and thus is in contrast to the study of Lin et al. [12].